289665-64-1 Usage
Type of drug
Antiretroviral
Purpose
Treating HIV/AIDS
Mechanism of action
Inhibits the activity of the reverse transcriptase enzyme, preventing HIV replication and spread
Classification
Nucleoside reverse transcriptase inhibitor (NRTI)
Group
Part of the larger group of antiretroviral drugs used in the treatment of HIV/AIDS
Current use
Less common due to potential toxicities and the development of newer, more effective antiretroviral drugs
Chemical structure
Complex, featuring a synthetic nucleoside analog
Development
Originally synthesized as a potential antiviral agent, later found to be effective against HIV
Administration
Oral
Side effects
Potential toxicities, including kidney and liver problems
Monitoring
Requires regular blood tests to monitor kidney and liver function during treatment
Resistance
HIV can develop resistance to ddI, limiting its effectiveness over time
Combination therapy
Often used in combination with other antiretroviral drugs to increase treatment effectiveness and reduce the risk of resistance development.
Check Digit Verification of cas no
The CAS Registry Mumber 289665-64-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,8,9,6,6 and 5 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 289665-64:
(8*2)+(7*8)+(6*9)+(5*6)+(4*6)+(3*5)+(2*6)+(1*4)=211
211 % 10 = 1
So 289665-64-1 is a valid CAS Registry Number.
289665-64-1Relevant academic research and scientific papers
Tian,Min,Zhang
, p. 1877 - 1889 (2000)
A new class of isonucleoside analogues with branched-sugar 2'-deoxy-2'-nucleobase-5'-deoxy-1',4'-anhydro-D-altritol (21, 23a-c) has been synthesized from D-glucose in 11 steps. The construction of branched-chain sugars has been carried out by hydroboration-oxidation of a double bond in the corresponding hexose. The key intermediate 12 was synthesized from the branched-chain sugar 11 by the reductive cleavage reaction in the presence of TMSOTf and triethylsilane. A strong solvent effect was observed in the intramolecular nucleophilic substitution of 12. The protic solvent is favorable to form the bicyclic compound 18 by double S(N)2 substitution. The opening reaction of epoxide 17 by nucleobases was achieved regioselectively to give the desired isonucleosides in reasonable yield. Copyright (C) 2000 Elsevier Science Ltd.